2
Participants
Start Date
March 31, 2004
Primary Completion Date
March 31, 2008
Study Completion Date
July 31, 2009
Busulfex
Given once daily for 4 days
Fludarabine
Given intravenously once daily for 4 days
Alemtuzumab
One day before fludarabine and busulfex are started, alemtuzumab will be given once daily for 5 days.
Stem Cell Transfusion
Performed three days after the end of chemotherapy
Winship Cancer Institute-Emory University, Atlanta
Ohio State University College of Medicine, Columbus
Feist-Weiller Cancer Center-LSU, Shreveport
Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center
OTHER
Massachusetts General Hospital
OTHER
Brigham and Women's Hospital
OTHER
Emory University
OTHER
Feist-Weiller Cancer Center at Louisiana State University Health Sciences
OTHER
Ohio State University
OTHER
Dana-Farber Cancer Institute
OTHER